期刊文献+

全耐药铜绿假单胞菌中多药外排泵mRNA表达的定量RT-PCR检测 预览 被引量:9

Measurement for mRNA levels of effiux pumps in clinical stains of Pseudomonas aeruginosa by real-time RT-PCR
在线阅读 下载PDF
分享 导出
摘要 目的 分析4种重要的药物外排泵系统在临床分离的全耐药铜绿假单胞菌与全敏感铜绿假单胞菌中表达的差异。方法 用SYBR GreenⅠ实时定量RT-PCR方法检测临床分离鉴定的全耐药和全敏感铜绿假单胞菌中4种外排泵MexAB-OprM、MexCD-OprJ、MexEF-OprN、MexXY-OprM的mRNA。结果 全耐药菌株较全敏感菌株多药外排泵MexAB、MexXY、MexCD、Mex-EF的mRNA表达明显增高(P〈0.01)。以敏感菌株拷贝平均数×4判定明显高表达,则全耐药菌MexAB高表达率为18.9%;MexXY高表达率为13.5%;MexCD高表达率为56.8%;MexEF高表达率为35.1%。37株全耐药菌有1种外排泵高表达的8株;2种外排泵高表达的10株;3种外排泵高表达的4株;4种外排泵同时高表达的2株,4种外排泵表达均未增高的有13株。结论 药物外排泵系统在临床全耐药铜绿假单胞菌耐药机制中起着重要作用,研究结果提示可能还存在其他耐药机制或存在外排泵功能与其表达量存在差异的情况。 Objective To evaluate the role of multi-drug efflux pumps system involved in the resistance of pan-time pseudomonas aeruginosas to antibiotics. Methods Established SYBR-Green Ⅰ real-time RT-PCR method was employed to quantify the mRNA levels of MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexXY-OpM and the differences of mRNA levels between pan-resistant P. aeruginosas and susceptible p. aeruglnosas were compared. Results The mRNA levels of MexAB-OprM, MexCD-OprJ, MexEF-OprN, MexXY-OprM in panresistant P. aeruginosas were higher than those in susceptible P. aeruginosas( P 〈 0.01 ). The percentage of overexpression was 18.9% in MexAB-OprM, 13.5% in MexCD-OprJ,56.8% in MexEF-OprN and 35.1% in MexXY-OprM respectively when the cutoff value was defined as four times of the mean value of susceptible P. aeruginosas. Conclusion The efflux pump system may play a key role in the resistance of pan-resistant Pseudomonas aeruginosas to antibiotics.
作者 周丹秋 李敏 蒋晓飞 阮斐怡 刘红 吕元 ZHOU Danqiu, LIMing, JIANG Xiaofei, et al. ( Center of Clinical Laboratory Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China)
出处 《临床检验杂志》 CAS 北大核心 2006年第2期 103-105,共3页 Chinese Journal of Clinical Laboratory Science
基金 上海市卫生局局级科研项目:上海市重点学科建设基金.
关键词 铜绿假单胞菌 全耐药 药物外排泵系统 Pseudomonas aeruginosa pan-resistant efflux-pump
作者简介 周丹秋,1967年生,女,硕士研究生,副主任技师,现在复旦大学附属金山医院检验科从事临床化学工作。 通迅作者:吕元,教授,E-mail:yuanlu@hsh.stn.sh.cn,电话:021-62498118。
  • 相关文献

参考文献7

  • 1Projan S J.Why is big pharma getting out of antibacterial drug discovery[J].Current Opinion in Microbiology ,2003,6:427-430. 被引量:1
  • 2Eldere J V.Multicentre surveillance of pseudomonas aeruginosa susceptibility patterns in nosoeomial infections [J].JAC,2003,51,347-352. 被引量:1
  • 3Cao B,Wang H,Sun H,et al.Risk factors and clinical outcomes of nosocomial multi-drug resistant pseudomonas aeruginosa infections[J].J Hosp infect,2004,57(2) :112-118. 被引量:1
  • 4Asboe D,Gant V,Aucken H M,et al.Persistence of Pseudomonas aeruginosa strains in respiratory infetion in AIDS patients [J].AIDS,1998,12 (14):1771-1775. 被引量:1
  • 5Jung R,Fish D N,Obritsch M D,et al.Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital [J].J Hosp infect,2004,57 (2):105-111. 被引量:1
  • 6Barrett JF.MC207-110 Daiichi Ssiyan/Microcide pharmaceuticals[J].Curr Opin lvesting Drugs,2001,2(2) :212-215. 被引量:1
  • 7Coban A Y,Ekinci B,Durupinar B.A multidrug effllux pump inhibitor reduces fluoroquinolone resistance in Pseudomonas aeruginosa isolates[J].Chemotherapy ,2004,50(1) :22-26. 被引量:1

同被引文献134

引证文献9

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈